Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapy

complications of transpupillary thermotherapy in exudative age-related macular degeneration

purpose: to evaluate the visual outcomes and complications of low power transpupillary thermotherapy (ttt) in patients with neovascular age-related macular degeneration (amd). methods: the study included 20 eyes of 17 patients. diagnosis of exudative amd was established on the basis of fundus examination and fluorescein angiography (fa). ttt was performed using a diode laser at 810 nm wavelengt...

[Transpupillary thermotherapy and age-related macular degeneration].

Transpupillary thermotherapy (TTT) has been proposed over the last a few years for the treatment of subfoveal occult choroidal neovessels resulting from age-related degeneration (AMD) when they are symptomatic and associated with exudation. Several pilot studies have shown how this technique can decrease or slow down the progression of exudation related to choroidal neovessels. Based on these p...

recent advances in treatment of age related macular degeneration

age related macular degeneration (amd) is the most common cause of visual impairment in the population above 64 years of age in developed countries. most cases of severe vision loss due to amd are caused by exudative changes in the macula. extensive research on amd has led to advances in its prophylaxis and treatment in recent years. photodynamic therapy (pdt) was developed in late 1990's ...

Recent advances in the treatment of age-related macular degeneration.

The Study of Serum Asymmetric Dimethylarginine Concentrations in the Different Paraoxonase Phenotypes of Exudative Age-related Macular Degeneration Disease

Background and Aims: Age-related macular degeneration (ARMD) is a degenerative retinal disorder that causes progressive loss of central vision in older adults. The study aimed to determine the effect of asymmetric dimethylarginine (ADMA) as oxidizing metabolite and paraoxonase (PON1) activity within its phenotypes as an antioxidant agent in the development of such multifactorial disease. Mater...